| DAY 1 - Friday, 18 October 2024 | ||
| 08.40 - 09.00 | Welcome and Introduction to EndoBridge 2024 | |
| 09.00 - 11.00 MAIN HALL |
Chairs: Sadi Gündoğdu, Aj van der Lely | |
| 09:00 - 09:30 | Management of Cushing disease - Jerome Bertherat | |
| 09:30 - 10:00 | Genetics of pituitary adenomas and their relevance in clinical care - Constantine Stratakis | |
| 10:00 - 10:30 | Management of acromegaly - Charlotte Hoybye | |
| 10:30 - 11:00 | Approach to aggressive pituitary tumors - Eliza B. Geer | |
| 11.00 - 11.20 | Coffee Break | |
| 11.20 - 12.50 | Interactive Case Discussion Sessions | |
| HALL A | Pituitary - Aj van der Lely, Misa Pfeifer | |
| HALL B | Adrenal - Gary Hammer, Laurence Amar | |
| HALL C | Neuroendocrine Tumors - Djuro Macut, Charlotte Hoybye | |
| HALL D | Male Reproductive Endocrinology - Dimitrios Goulis, Chrysanthi Balodimou | |
| 12.50 - 14.00 | Lunch | |
| 14.00 - 15.30 | Interactive Case Discussion Sessions | |
| HALL A | Pituitary - Eliza B. Geer, Aj van der Lely | |
| HALL B | Adrenal - Jerome Bertherat, Constantine Stratakis | |
| HALL C | Neuroendocrine Tumors - Djuro Macut, Charlotte Hoybye | |
| HALL D | Female Reproductive Endocrinology - Eleni Armeni, Duarte Pignatelli | |
| 15.30 - 15.50 | Coffee Break | |
| 15.50 - 17.50 MAIN HALL |
Chairs: Bülent O. Yıldız, Duarte Pignatelli | |
| 15:50 - 16:20 | Hormonal management of menopause and POI - Eleni Armeni | |
| 16:20 - 16:50 | Updates on male hypogonadism and infertility - Dimitrios Goulis | |
| 16:50 - 17:20 | Primary aldosteronism - Laurence Amar | |
| 17:20 - 17:50 | Adrenal Insufficiency - common and rare causes – from biology to clinical care - Gary Hammer | |
| DAY 2 - Saturday, 19 October 2024 | ||
| 09.00 - 11.00 MAIN HALL |
Chairs: Nicola Napoli, Dilek Yazıcı | |
| 09:00 - 09:30 | Osteoporosis in children and adolescents - Catherine Gordon | |
| 09:30 - 10:00 | Diabetes, obesity and bones - Nicola Napoli | |
| 10:00 - 10:30 | Bone loss and fractures post denosumab discontinuation - Bente Langdahl | |
| 10:30 - 11:00 | Goal directed therapy- BHOF- ASBMR position - Ghada El-Hajj Fuleihan | |
| 11.00 - 11.20 | Coffee Break | |
| 11.20 - 12.50 | Interactive Case Discussion Sessions | |
| HALL A | Diabetes - Viral Shah, Gerlies Treiber | |
| HALL B | Thyroid - Bernadette Biondi, Tim Korevaar | |
| HALL C | Bone and Calcium - Ghada El-Hajj Fuleihan, Catherine Gordon | |
| HALL D | Obesity, Metabolism and Nutrition - John Wilding, Andreea Ciudin | |
| 12.50 - 14.00 | Lunch | |
| 14.00 - 15.30 | Interactive Case Discussion Sessions | |
| HALL A | Diabetes - Julia Mader, Pieter Gillard | |
| HALL B | Thyroid - Susan Mandel, Matthew Ringel | |
| HALL C | Bone and Calcium - Bente Langdahl, Nicola Napoli | |
| HALL D | Obesity, Metabolism and Nutrition - Gema Frühbeck, Barbara McGowan | |
| 15.30 - 15.50 | Coffee Break | |
| 15.50 - 17.50 MAIN HALL |
Chairs: Tim Korevaar, İnan Anaforoğlu |  |
| 15:50 - 16:20 | Update on ATA pregnancy guidelines - Tim Korevaar | |
| 16:20 - 16:50 | Update on ATA nodule guidelines - Susan Mandel | |
| 16:50 - 17:20 | Update on ATA cancer guidelines - Matthew Ringel | |
| 17:20 - 17:50 | Treatment of subclinical thyroid disease - Bernadette Biondi | |
| DAY 3 - Sunday, 20 October 2024 | ||
| 09.00 - 11.00 MAIN HALL |
Chairs: Barbara McGowan, Mustafa Cesur |  |
| 09:00 - 09:30 | Phenotyping obesities: Reality or utopia - Gema Frühbeck | |
| 09:30 - 10:00 | Evidence and experience-based obesity pharmacotherapy - John Wilding | |
| 10:00 - 10:30 | Obesity management in preventing and treating MASLD - Andreea Ciudin | |
| 10:30 - 11:00 | GLP-1R agonists & cardiovascular outcomes in obesity without diabetes - Barbara McGowan | |
| 11.00 - 11.20 | Coffee Break | |
| 11.20 - 13.20 MAIN HALL |
Chairs: Pieter Gillard, Özlem Çelik |  |
| 11:20 - 11:50 | Diabetes in pregnancy - Gerlies Treiber | |
| 11:50 - 12:20 | Revolutionizing diabetes management with once weekly insulins - Julia Mader | |
| 12:20 - 12:50 | Adjunct therapies for type 1 diabetes - Pieter Gillard | |
| 12:50 - 13:20 | Technology in T2DM - Viral Shah | |
| 13.20 - 13.30 | Closing comments and adjourn | |